D.A. Davidson & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $533K | Buy |
2,720
+431
| +19% | +$83.7K | ﹤0.01% | 1152 |
|
|
2025
Q4 | $397K | Buy |
2,289
+255
| +13% | +$46.4K | ﹤0.01% | 1230 |
|
|
2025
Q3 | $388K | Buy |
2,034
+916
| +82% | +$163K | ﹤0.01% | 1219 |
|
|
2025
Q2 | $201K | Buy |
+1,118
| New | +$194K | ﹤0.01% | 1366 |
|
|
2021
Q3 | – | Sell |
-1,607
| Closed | -$212K | – | 1222 |
|
|
2021
Q2 | $212K | Sell |
1,607
-100
| -6% | -$13.1K | ﹤0.01% | 1112 |
|
|
2021
Q1 | $219K | Buy |
+1,707
| New | +$210K | ﹤0.01% | 1062 |
|
|
2020
Q3 | – | Sell |
-3,855
| Closed | -$439K | – | 957 |
|
|
2020
Q2 | $439K | Sell |
3,855
-62
| -2% | -$6.58K | 0.01% | 638 |
|
|
2020
Q1 | $315K | Buy |
3,917
+1,773
| +83% | +$184K | 0.01% | 724 |
|
|
2019
Q4 | $229K | Buy |
+2,144
| New | +$224K | ﹤0.01% | 912 |
|
|
2019
Q2 | – | Sell |
-8,079
| Closed | -$708K | – | 1034 |
|
|
2019
Q1 | $708K | Sell |
8,079
-729
| -8% | -$63.2K | 0.01% | 589 |
|
|
2018
Q4 | $733K | Buy |
8,808
+2,093
| +31% | +$196K | 0.01% | 551 |
|
|
2018
Q3 | $725K | Buy |
6,715
+164
| +3% | +$18K | 0.01% | 596 |
|
|
2018
Q2 | $720K | Sell |
6,551
-11
| -0.2% | -$1.15K | 0.01% | 597 |
|
|
2018
Q1 | $658K | Sell |
6,562
-569
| -8% | -$58.3K | 0.01% | 598 |
|
|
2017
Q4 | $702K | Sell |
7,131
-4,850
| -40% | -$460K | 0.01% | 552 |
|
|
2017
Q3 | $1.12M | Sell |
11,981
-807
| -6% | -$85.7K | 0.02% | 472 |
|
|
2017
Q2 | $1.42M | Buy |
12,788
+147
| +1% | +$15.5K | 0.03% | 383 |
|
|
2017
Q1 | $1.24M | Sell |
12,641
-1,128
| -8% | -$108K | 0.03% | 395 |
|
|
2016
Q4 | $1.26M | Sell |
13,769
-630
| -4% | -$54.3K | 0.03% | 421 |
|
|
2016
Q3 | $1.22M | Buy |
14,399
+10,921
| +314% | +$917K | 0.03% | 416 |
|
|
2016
Q2 | $279K | Sell |
3,478
-377
| -10% | -$28.7K | 0.01% | 732 |
|
|
2016
Q1 | $273K | Buy |
3,855
+131
| +4% | +$8.79K | 0.01% | 721 |
|
|
2015
Q4 | $263K | Sell |
3,724
-80
| -2% | -$5.38K | 0.01% | 752 |
|
|
2015
Q3 | $231K | Buy |
3,804
+82
| +2% | +$5.73K | 0.01% | 776 |
|
|
2015
Q2 | $268K | Sell |
3,722
-861
| -19% | -$63.6K | 0.01% | 756 |
|
|
2015
Q1 | $350K | Sell |
4,583
-164
| -3% | -$11.7K | 0.01% | 679 |
|
|
2014
Q4 | $317K | Buy |
4,747
+124
| +3% | +$7.83K | 0.01% | 711 |
|
|
2014
Q3 | $279K | Buy |
4,623
+237
| +5% | +$14.6K | 0.01% | 762 |
|
|
2014
Q2 | $256K | Buy |
4,386
+329
| +8% | +$19.3K | 0.01% | 800 |
|
|
2014
Q1 | $234K | Buy |
4,057
+3,024
| +293% | +$162K | 0.01% | 822 |
|
|
2013
Q4 | $54K | Buy |
1,033
+40
| +4% | +$2.37K | ﹤0.01% | 1302 |
|
|
2013
Q3 | $61K | Hold |
993
| – | – | ﹤0.01% | 1077 |
|
|
2013
Q2 | $59K | Buy |
+993
| New | +$59.2K | ﹤0.01% | 1055 |
|
Other funds holding DGX
VCM
VPM
EIG
D.A. Davidson & Co's DGX Position: Q1 2026 in Review
D.A. Davidson & Co increased its Quest Diagnostics (DGX) stake by 19% in Q1 2026, buying an estimated $83.7K and bringing the position to 2,720 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.
D.A. Davidson & Co first reported a position in DGX in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.42M in Q2 2017. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- D.A. Davidson & Co held 2,720 shares of Quest Diagnostics worth $533K as of Q1 2026.
- D.A. Davidson & Co bought 431 Quest Diagnostics shares in Q1 2026, an estimated $83.7K.
- Quest Diagnostics made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #1152 holding.
- D.A. Davidson & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 33 quarters since.
- D.A. Davidson & Co's Quest Diagnostics position peaked at $1.42M in Q2 2017.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.